Editorial: Quo Vadis Lipid Mediators – Lipid Mediators Implication in Inflammation and Chronic Inflammatory Diseases
Main Authors: | Danuta Radzioch, Martin Giera, Juan Bautista De Sanctis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.699276/full |
Similar Items
-
Associations of genotype variants of single nucleotide polymorphism of gene orosomucoid-1-like-protein 3 and atopic diseases at children.
by: V. O. Dytiatkovsky, et al.
Published: (2019-11-01) -
Repression by the Arabidopsis TOPLESS corepressor requires association with the core mediator complex
by: Alexander R Leydon, et al.
Published: (2021-06-01) -
Pentraxin 3 promotes airway inflammation in experimental asthma
by: Pengfei Gao, et al.
Published: (2020-09-01) -
Phosphorylation-Dependent Regulation of the Corepressor SMRT
by: Stanya, Kristopher J.
Published: (2009) -
2-Chlorofatty acids: lipid mediators of neutrophil extracellular trap formation
by: ElisaN.D. Palladino, et al.
Published: (2018-08-01)